Crossject is revolutionizing needle free injection

Paragraphes

Crossject is revolutionizing the administration of well-established treatments with its needle-free auto-injector ZENEO®. The prefilled, single-use device propels the medicine through the skin in less than a tenth of a second. Crossject currently has eight solutions in advanced stages of development, seven of which are for emergency situations.  

Zeneo illustration

 

Our news

Image de l'actualité

JP Morgan Healthcare Annual Meeting 2022

Résumé de l'actualité

Make the most of your virtual JPM22 by connecting with Crossject’s Business development team!

Image de l'actualité

Season greetings

Résumé de l'actualité
Carte de voeux 2022